Philips Secures FDA Clearance for SmartSpeed Precise, Advancing MRI Speed and Image Precision

Dual AI-Powered Imaging Software Set to Enhance Diagnostic Confidence and Workflow Efficiency in MRI

Philips’ SmartSpeed Precise represents a landmark innovation in MRI technology, receiving FDA 510(k) clearance as the industry’s first dual AI-powered image reconstruction software. The solution integrates Philips’ Compressed SENSE acceleration engine with two distinct AI algorithms—one for denoising and another for image sharpening—creating a highly efficient and intelligent imaging platform. This deep learning-based solution enables faster, clearer scans with a simplified, single-click workflow. By achieving FDA clearance, Philips validates the clinical safety and efficacy of SmartSpeed Precise, opening the door for widespread clinical adoption across its entire 1.5T and 3.0T MRI system portfolio, including existing installed systems.


Designed for real-world radiology demands, SmartSpeed Precise offers significant improvements in operational efficiency, scan speed, and image quality. The system delivers up to 3x faster scans and up to 80% sharper images, allowing radiology departments to handle greater patient volumes while maintaining diagnostic precision. With its one-click functionality and adaptable denoising settings, it supports both experienced and junior technologists, standardizing imaging results across patients and reducing variability. From challenging cases such as pediatric and elderly patients to high-demand areas like neurology and oncology, SmartSpeed Precise enhances workflow reliability, improves diagnostic confidence, and reduces patient discomfort through shorter exam times—including a sub-10-second brain scan.

Sign up for Blog Updates